Atrial septal defect occluders

Atrial Septal Defect Microchapters
Home
Patient Information
Overview
Anatomy
Classification
Ostium Secundum Atrial Septal Defect
Ostium Primum Atrial Septal Defect
Sinus Venosus Atrial Septal Defect
Coronary Sinus
Patent Foramen Ovale
Common or Single Atrium
Pathophysiology
Epidemiology and Demographics
Risk Factors
Natural History and Prognosis
Complications
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Transesophageal Echocardiography
Transthoracic Echocardiography
Contrast Echocardiography
M-Mode
Doppler
Transcranial Doppler Ultrasound
Cardiac Catheterization
Exercise Testing
ACC/AHA Guidelines for Evaluation of Unoperated Patients
Treatment
Medical Therapy
Surgery
Indications for Surgical Repair
Surgical Closure
Minimally Invasive Repair
Robotic ASD Repair
Percutaneous Closure
Post-Surgical Follow Up
Special Scenarios
Pregnancy
Diving and Decompression Sickness
Paradoxical Emboli
Pulmonary Hypertension
Eisenmenger's Syndrome
Atmospheric Pressure
Case Studies
Case #1
Atrial septal defect occluders On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atrial septal defect occluders All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atrial septal defect occluders
CDC on Atrial septal defect occluders
Atrial septal defect occluders in the news
Blogs on Atrial septal defect occluders
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Atrial septal defect occluders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [[2]]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]

Overview

Percutaneous transcatheter closure is used in limited atrial septal defect cases. The Food and Drug Administration has only authorized the use of percutaneous closure in ostium secundum patients.

The Food and Drug Administration authorized Occluders

The Food and Drug Administration has authorized the following percutaenous transcatheters for usage:

• Amplatzer septal occluder
• CardioSEAL
• HELEX septal occluder
• Sideris patch